Related Content
Search Google Scholar for:
|
|
Science 27 May 1994: Vol. 264. no. 5163, pp. 1336 - 1340 DOI: 10.1126/science.8191290
|
|
Articles
Science, Vol 264, Issue 5163, 1336-1340
Copyright © 1994 by American Association for the Advancement of Science
An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants
N Suzuki,
TT Cheung,
XD Cai,
A Odaka,
L Otvos Jr,
C Eckman,
TE Golde,
and
SG Younkin
Discovery Research Division, Takeda Chemical Industries, Ltd., Ibaraki, Japan.
Normal processing of the amyloid beta protein precursor (beta APP) results in secretion of a soluble 4-kilodalton protein essentially identical to the amyloid beta protein (A beta) that forms insoluble fibrillar deposits in Alzheimer's disease. Human neuroblastoma (M17) cells transfected with constructs expressing wild-type beta APP or the beta APP717 mutants linked to familial Alzheimer's disease were compared by (i) isolation of metabolically labeled 4-kilodalton A beta from conditioned medium, digestion with cyanogen bromide, and analysis of the carboxyl-terminal peptides released, or (ii) analysis of the A beta in conditioned medium with sandwich enzyme-linked immunosorbent assays that discriminate A beta 1-40 from the longer A beta 1-42. Both methods demonstrated that the 4-kilodalton A beta released from wild-type beta APP is primarily but not exclusively A beta 1-40. The beta APP717 mutations, which are located three residues carboxyl to A beta 43, consistently caused a 1.5- to 1.9-fold increase in the percentage of longer A beta generated. Long A beta (for example, A beta 1-42) forms insoluble amyloid fibrils more rapidly than A beta 1-40. Thus, the beta APP717 mutants may cause Alzheimer's disease because they secrete increased amounts of long A beta, thereby fostering amyloid deposition.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity.
- K. Usui, J. D. Hulleman, J. F. Paulsson, S. J. Siegel, E. T. Powers, and J. W. Kelly (2009)
PNAS
106, 18563-18568
| Abstract »
| Full Text »
| PDF »
- Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease.
- S. Peng, D. J. Garzon, M. Marchese, W. Klein, S. D. Ginsberg, B. M. Francis, H. T. J. Mount, E. J. Mufson, A. Salehi, and M. Fahnestock (2009)
J. Neurosci.
29, 9321-9329
| Abstract »
| Full Text »
| PDF »
- Deletion of the {alpha}7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease.
- G. Dziewczapolski, C. M. Glogowski, E. Masliah, and S. F. Heinemann (2009)
J. Neurosci.
29, 8805-8815
| Abstract »
| Full Text »
| PDF »
- Amyloid {beta}-Protein Toxicity and the Pathogenesis of Alzheimer Disease.
- B. A. Yankner and T. Lu (2009)
J. Biol. Chem.
284, 4755-4759
| Full Text »
| PDF »
- The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid {beta} Peptides in an in Vitro Model of the Blood-Brain Barrier Cells.
- K. Yamada, T. Hashimoto, C. Yabuki, Y. Nagae, M. Tachikawa, D. K. Strickland, Q. Liu, G. Bu, J. M. Basak, D. M. Holtzman, et al. (2008)
J. Biol. Chem.
283, 34554-34562
| Abstract »
| Full Text »
| PDF »
- Retinoic Acid Attenuates {beta}-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model.
- Y. Ding, A. Qiao, Z. Wang, J. S. Goodwin, E.-S. Lee, M. L. Block, M. Allsbrook, M. P. McDonald, and G.-H. Fan (2008)
J. Neurosci.
28, 11622-11634
| Abstract »
| Full Text »
| PDF »
- Phosphoinositides Suppress {gamma}-Secretase in Both the Detergent-soluble and -insoluble States.
- S. Osawa, S. Funamoto, M. Nobuhara, S. Wada-Kakuda, M. Shimojo, S. Yagishita, and Y. Ihara (2008)
J. Biol. Chem.
283, 19283-19292
| Abstract »
| Full Text »
| PDF »
- Inhibition of {gamma}-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes.
- R. A. Sharples, L. J. Vella, R. M. Nisbet, R. Naylor, K. Perez, K. J. Barnham, C. L. Masters, and A. F. Hill (2008)
FASEB J
22, 1469-1478
| Abstract »
| Full Text »
| PDF »
- 5-Lipoxygenase gene disruption reduces amyloid-{beta} pathology in a mouse model of Alzheimer's disease.
- O. Firuzi, J. Zhuo, C. M. Chinnici, T. Wisniewski, and D. Pratico (2008)
FASEB J
22, 1169-1178
| Abstract »
| Full Text »
| PDF »
- Plasma amyloid {beta} protein is elevated in late-onset Alzheimer disease families.
- N. Ertekin-Taner, L. H. Younkin, D. M. Yager, F. Parfitt, M. C. Baker, S. Asthana, M. L. Hutton, S. G. Younkin, and N. R. Graff-Radford (2008)
Neurology
70, 596-606
| Abstract »
| Full Text »
| PDF »
- Genetic association of CTNNA3 with late-onset Alzheimer's disease in females.
- A. Miyashita, H. Arai, T. Asada, M. Imagawa, E. Matsubara, M. Shoji, S. Higuchi, K. Urakami, A. Kakita, H. Takahashi, et al. (2007)
Hum. Mol. Genet.
16, 2854-2869
| Abstract »
| Full Text »
| PDF »
- Rodent Abeta Modulates the Solubility and Distribution of Amyloid Deposits in Transgenic Mice.
- J. L. Jankowsky, L. H. Younkin, V. Gonzales, D. J. Fadale, H. H. Slunt, H. A. Lester, S. G. Younkin, and D. R. Borchelt (2007)
J. Biol. Chem.
282, 22707-22720
| Abstract »
| Full Text »
| PDF »
- Accelerated A{beta} Deposition in APPswe/PS1{Delta}E9 Mice with Hemizygous Deletions of TTR (Transthyretin).
- S. H. Choi, S. N. Leight, V. M.-Y. Lee, T. Li, P. C. Wong, J. A. Johnson, M. J. Saraiva, and S. S. Sisodia (2007)
J. Neurosci.
27, 7006-7010
| Abstract »
| Full Text »
| PDF »
- Involvement of -site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity.
- H. Ma, S. Lesne, L. Kotilinek, J. V. Steidl-Nichols, M. Sherman, L. Younkin, S. Younkin, C. Forster, N. Sergeant, A. Delacourte, et al. (2007)
PNAS
104, 8167-8172
| Abstract »
| Full Text »
| PDF »
- Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis.
- M. S. Forman, E. J. Mufson, S. Leurgans, D. Pratico, S. Joyce, S. Leight, V. M.-Y. Lee, and J. Q. Trojanowski (2007)
Neurology
68, 757-763
| Abstract »
| Full Text »
| PDF »
- The Tottori (D7N) and English (H6R) Familial Alzheimer Disease Mutations Accelerate Abeta Fibril Formation without Increasing Protofibril Formation.
- Y. Hori, T. Hashimoto, Y. Wakutani, K. Urakami, K. Nakashima, M. M. Condron, S. Tsubuki, T. C. Saido, D. B. Teplow, and T. Iwatsubo (2007)
J. Biol. Chem.
282, 4916-4923
| Abstract »
| Full Text »
| PDF »
- A review of genome mutation and Alzheimer's disease.
- P. Thomas and M. Fenech (2007)
Mutagenesis
22, 15-33
| Abstract »
| Full Text »
| PDF »
- A Century of Alzheimer's Disease.
- M. Goedert and M. G. Spillantini (2006)
Science
314, 777-781
| Abstract »
| Full Text »
| PDF »
- Therapeutic approaches to Alzheimer's disease.
- H.-W. Klafki, M. Staufenbiel, J. Kornhuber, and J. Wiltfang (2006)
Brain
129, 2840-2855
| Abstract »
| Full Text »
| PDF »
- Acceleration of Amyloid beta-Peptide Aggregation by Physiological Concentrations of Calcium.
- A. M. Isaacs, D. B. Senn, M. Yuan, J. P. Shine, and B. A. Yankner (2006)
J. Biol. Chem.
281, 27916-27923
| Abstract »
| Full Text »
| PDF »
- Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-beta Peptides Abeta40 and Abeta42: STABLE TRIMER OR TETRAMER FORMATION BY Abeta42.
- Y.-R. Chen and C. G. Glabe (2006)
J. Biol. Chem.
281, 24414-24422
| Abstract »
| Full Text »
| PDF »
- Age and Apolipoprotein E*4 Allele Effects on Cerebrospinal Fluid beta-Amyloid 42 in Adults With Normal Cognition..
- E. R. Peskind, G. Li, J. Shofer, J. F. Quinn, J. A. Kaye, C. M. Clark, M. R. Farlow, C. DeCarli, M. A. Raskind, G. D. Schellenberg, et al. (2006)
Arch Neurol
63, 936-939
| Abstract »
| Full Text »
| PDF »
- Phosphorylation of Amyloid Precursor Protein (APP) at Thr668 Regulates the Nuclear Translocation of the APP Intracellular Domain and Induces Neurodegeneration..
- K.-A Chang, H.-S. Kim, T.-Y. Ha, J.-W. Ha, K. Y. Shin, Y. H. Jeong, J.-P. Lee, C.-H. Park, S. Kim, T.-K. Baik, et al. (2006)
Mol. Cell. Biol.
26, 4327-4338
| Abstract »
| Full Text »
| PDF »
- Reductions in levels of the Alzheimer's amyloid {beta} peptide after oral administration of ginsenosides.
- F. Chen, E. A. Eckman, and C. B. Eckman (2006)
FASEB J
20, 1269-1271
| Abstract »
| Full Text »
| PDF »
- {beta}-Amyloid Mediated Nitration of Manganese Superoxide Dismutase: Implication for Oxidative Stress in a APPNLh/NLh X PS-1P264L/P264L Double Knock-In Mouse Model of Alzheimer's Disease.
- M. Anantharaman, J. Tangpong, J. N. Keller, M. P. Murphy, W. R. Markesbery, K. K. Kiningham, and D. K. St. Clair (2006)
Am. J. Pathol.
168, 1608-1618
| Abstract »
| Full Text »
| PDF »
- Inclusion-body myositis and Alzheimer disease: Two sides of the same coin, or different currencies altogether?.
- M. P. Murphy and T. E. Golde (2006)
Neurology
66, S65-S68
| Full Text »
| PDF »
- The Solvent Protection of Alzheimer Amyloid-{beta}-(1-42) Fibrils as Determined by Solution NMR Spectroscopy.
- A. Olofsson, A. E. Sauer-Eriksson, and A. Ohman (2006)
J. Biol. Chem.
281, 477-483
| Abstract »
| Full Text »
| PDF »
- Defective Tumor Necrosis Factor-{alpha}-dependent Control of Astrocyte Glutamate Release in a Transgenic Mouse Model of Alzheimer Disease.
- D. Rossi, L. Brambilla, C. F. Valori, A. Crugnola, G. Giaccone, R. Capobianco, M. Mangieri, A. E. Kingston, A. Bloc, P. Bezzi, et al. (2005)
J. Biol. Chem.
280, 42088-42096
| Abstract »
| Full Text »
| PDF »
- Choroid Plexus Megalin Is Involved in Neuroprotection by Serum Insulin-Like Growth Factor I.
- E. Carro, C. Spuch, J. L. Trejo, D. Antequera, and I. Torres-Aleman (2005)
J. Neurosci.
25, 10884-10893
| Abstract »
| Full Text »
| PDF »
- Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer {beta}-amyloid peptide in rodent.
- N. H. Greig, T. Utsuki, D. K. Ingram, Y. Wang, G. Pepeu, C. Scali, Q.-S. Yu, J. Mamczarz, H. W. Holloway, T. Giordano, et al. (2005)
PNAS
102, 17213-17218
| Abstract »
| Full Text »
| PDF »
- Transforming Growth Factor {beta}2 Is a Neuronal Death-Inducing Ligand for Amyloid-{beta} Precursor Protein.
- Y. Hashimoto, T. Chiba, M. Yamada, M. Nawa, K. Kanekura, H. Suzuki, K. Terashita, S. Aiso, I. Nishimoto, and M. Matsuoka (2005)
Mol. Cell. Biol.
25, 9304-9317
| Abstract »
| Full Text »
| PDF »
- Estrogen Therapy Fails to Alter Amyloid Deposition in the PDAPP Model of Alzheimer's Disease.
- P. S. Green, K. Bales, S. Paul, and G. Bu (2005)
Endocrinology
146, 2774-2781
| Abstract »
| Full Text »
| PDF »
- CLAC Binds to Amyloid {beta} Peptides through the Positively Charged Amino Acid Cluster within the Collagenous Domain 1 and Inhibits Formation of Amyloid Fibrils.
- Y. Osada, T. Hashimoto, A. Nishimura, Y. Matsuo, T. Wakabayashi, and T. Iwatsubo (2005)
J. Biol. Chem.
280, 8596-8605
| Abstract »
| Full Text »
| PDF »
- Elevated amyloid {beta} protein (A{beta}42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.
- N. Ertekin-Taner, J. Ronald, L. Feuk, J. Prince, M. Tucker, L. Younkin, M. Hella, S. Jain, A. Hackett, L. Scanlin, et al. (2005)
Hum. Mol. Genet.
14, 447-460
| Abstract »
| Full Text »
| PDF »
- Longer Forms of Amyloid {beta} Protein: Implications for the Mechanism of Intramembrane Cleavage by {gamma}-Secretase.
- Y. Qi-Takahara, M. Morishima-Kawashima, Y. Tanimura, G. Dolios, N. Hirotani, Y. Horikoshi, F. Kametani, M. Maeda, T. C. Saido, R. Wang, et al. (2005)
J. Neurosci.
25, 436-445
| Abstract »
| Full Text »
| PDF »
- Evaluation of the safety and immunogenicity of synthetic A{beta}42 (AN1792) in patients with AD.
- A. J. Bayer, R. Bullock, R. W. Jones, D. Wilkinson, K. R. Paterson, L. Jenkins, S. B. Millais, and S. Donoghue (2005)
Neurology
64, 94-101
| Abstract »
| Full Text »
| PDF »
- Altered Amyloid-{beta} Metabolism and Deposition in Genomic-based {beta}-Secretase Transgenic Mice.
- M. J. Chiocco, L. S. Kulnane, L. Younkin, S. Younkin, G. Evin, and B. T. Lamb (2004)
J. Biol. Chem.
279, 52535-52542
| Abstract »
| Full Text »
| PDF »
- Single Transmembrane Spanning Heterotrimeric G Protein-Coupled Receptors and Their Signaling Cascades.
- T. B. Patel (2004)
Pharmacol. Rev.
56, 371-385
| Abstract »
| Full Text »
| PDF »
- Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease.
- J. Brown III, C. Theisler, S. Silberman, D. Magnuson, N. Gottardi-Littell, J. M. Lee, D. Yager, J. Crowley, K. Sambamurti, M. M. Rahman, et al. (2004)
J. Biol. Chem.
279, 34674-34681
| Abstract »
| Full Text »
| PDF »
- Effects of Neprilysin Chimeric Proteins Targeted to Subcellular Compartments on Amyloid {beta} Peptide Clearance in Primary Neurons.
- E. Hama, K. Shirotani, N. Iwata, and T. C. Saido (2004)
J. Biol. Chem.
279, 30259-30264
| Abstract »
| Full Text »
| PDF »
- Mostly Separate Distributions of CLAC- versus A{beta}40- or Thioflavin S-Reactivities in Senile Plaques Reveal Two Distinct Subpopulations of {beta}-Amyloid Deposits.
- H. Kowa, T. Sakakura, Y. Matsuura, T. Wakabayashi, D. M.A. Mann, K. Duff, S. Tsuji, T. Hashimoto, and T. Iwatsubo (2004)
Am. J. Pathol.
165, 273-281
| Abstract »
| Full Text »
| PDF »
- Luteinizing Hormone, a Reproductive Regulator That Modulates the Processing of Amyloid-{beta} Precursor Protein and Amyloid-{beta} Deposition.
- R. L. Bowen, G. Verdile, T. Liu, A. F. Parlow, G. Perry, M. A. Smith, R. N. Martins, and C. S. Atwood (2004)
J. Biol. Chem.
279, 20539-20545
| Abstract »
| Full Text »
| PDF »
- Dimeric Amyloid {beta} Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's Disease.
- T. Kawarabayashi, M. Shoji, L. H. Younkin, L. Wen-Lang, D. W. Dickson, T. Murakami, E. Matsubara, K. Abe, K. H. Ashe, and S. G. Younkin (2004)
J. Neurosci.
24, 3801-3809
| Abstract »
| Full Text »
| PDF »
- Metabolite-initiated protein misfolding may trigger Alzheimer's disease.
- Q. Zhang, E. T. Powers, J. Nieva, M. E. Huff, M. A. Dendle, J. Bieschke, C. G. Glabe, A. Eschenmoser, P. Wentworth Jr., R. A. Lerner, et al. (2004)
PNAS
101, 4752-4757
| Abstract »
| Full Text »
| PDF »
- {beta}-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain.
- H. Fukumoto, D. L. Rosene, M. B. Moss, S. Raju, B. T. Hyman, and M. C. Irizarry (2004)
Am. J. Pathol.
164, 719-725
| Abstract »
| Full Text »
| PDF »
- Mutant presenilins specifically elevate the levels of the 42 residue {beta}-amyloid peptide in vivo: evidence for augmentation of a 42-specific {gamma} secretase.
- J. L. Jankowsky, D. J. Fadale, J. Anderson, G. M. Xu, V. Gonzales, N. A. Jenkins, N. G. Copeland, M. K. Lee, L. H. Younkin, S. L. Wagner, et al. (2004)
Hum. Mol. Genet.
13, 159-170
| Abstract »
| Full Text »
| PDF »
- Fine mapping of the {alpha}-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.
- N. Ertekin-Taner, J. Ronald, H. Asahara, L. Younkin, M. Hella, S. Jain, E. Gnida, S. Younkin, D. Fadale, Y. Ohyagi, et al. (2003)
Hum. Mol. Genet.
12, 3133-3143
| Abstract »
| Full Text »
| PDF »
- Cerebrospinal Fluid Tau and {beta}-Amyloid: How Well Do These Biomarkers Reflect Autopsy-Confirmed Dementia Diagnoses?.
- C. M. Clark, S. Xie, J. Chittams, D. Ewbank, E. Peskind, D. Galasko, J. C. Morris, D. W. McKeel Jr, M. Farlow, S. L. Weitlauf, et al. (2003)
Arch Neurol
60, 1696-1702
| Abstract »
| Full Text »
| PDF »
- Genetic background regulates {beta}-amyloid precursor protein processing and {beta}-amyloid deposition in the mouse.
- E. J.H. Lehman, L. S. Kulnane, Y. Gao, M. C. Petriello, K. M. Pimpis, L. Younkin, G. Dolios, R. Wang, S. G. Younkin, and B. T. Lamb (2003)
Hum. Mol. Genet.
12, 2949-2956
| Abstract »
| Full Text »
| PDF »
- Cu2+-induced modification of the kinetics of A{beta}(1-42) channels.
- R. Bahadi, P. V. Farrelly, B. L. Kenna, C. C. Curtain, C. L. Masters, R. Cappai, K. J. Barnham, and J. I. Kourie (2003)
Am J Physiol Cell Physiol
285, C873-C880
| Abstract »
| Full Text »
| PDF »
- The Non-cyclooxygenase Targets of Non-steroidal Anti-inflammatory Drugs, Lipoxygenases, Peroxisome Proliferator-activated Receptor, Inhibitor of {kappa}B Kinase, and NF{kappa}B, Do Not Reduce Amyloid {beta}42 Production.
- S. A. Sagi, S. Weggen, J. Eriksen, T. E. Golde, and E. H. Koo (2003)
J. Biol. Chem.
278, 31825-31830
| Abstract »
| Full Text »
| PDF »
- Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid {beta}42 Production by Direct Modulation of {gamma}-Secretase Activity.
- S. Weggen, J. L. Eriksen, S. A. Sagi, C. U. Pietrzik, V. Ozols, A. Fauq, Todd. E. Golde, and E. H. Koo (2003)
J. Biol. Chem.
278, 31831-31837
| Abstract »
| Full Text »
| PDF »
- Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation: OXIDATIVE STRESS, CASPASES, AND THE JNK PATHWAY.
- C. A. Marques, U. Keil, A. Bonert, B. Steiner, C. Haass, W. E. Muller, and A. Eckert (2003)
J. Biol. Chem.
278, 28294-28302
| Abstract »
| Full Text »
| PDF »
- Glycation of the amyloid {beta}-protein by a nicotine metabolite: A fortuitous chemical dynamic between smoking and Alzheimer's disease.
- T. J. Dickerson and K. D. Janda (2003)
PNAS
100, 8182-8187
| Abstract »
| Full Text »
| PDF »
- Specific Compositions of Amyloid-{beta} Peptides as the Determinant of Toxic {beta}-Aggregation.
- Y. Yoshiike, D.-H. Chui, T. Akagi, N. Tanaka, and A. Takashima (2003)
J. Biol. Chem.
278, 23648-23655
| Abstract »
| Full Text »
| PDF »
- Identification of a Mutant Amyloid Peptide That Predominantly Forms Neurotoxic Protofibrillar Aggregates.
- I. Qahwash, K. L. Weiland, Y. Lu, R. W. Sarver, R. F. Kletzien, and R. Yan (2003)
J. Biol. Chem.
278, 23187-23195
| Abstract »
| Full Text »
| PDF »
- The {gamma}-Secretase Inhibitor N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl Ester Reduces A{beta} Levels in Vivo in Plasma and Cerebrospinal Fluid in Young (Plaque-Free) and Aged (Plaque-Bearing) Tg2576 Mice.
- T. A. Lanz, C. S. Himes, G. Pallante, L. Adams, S. Yamazaki, B. Amore, and K. M. Merchant (2003)
J. Pharmacol. Exp. Ther.
305, 864-871
| Abstract »
| Full Text »
| PDF »
- Neurofibrillary Tangles, Amyloid, and Memory in Aging and Mild Cognitive Impairment.
- A. L. Guillozet, S. Weintraub, D. C. Mash, and M. M. Mesulam (2003)
Arch Neurol
60, 729-736
| Abstract »
| Full Text »
| PDF »
- gamma -Secretase Cleavage Site Specificity Differs for Intracellular and Secretory Amyloid beta.
- H. S. Grimm, D. Beher, S. F. Lichtenthaler, M. S. Shearman, K. Beyreuther, and T. Hartmann (2003)
J. Biol. Chem.
278, 13077-13085
| Abstract »
| Full Text »
| PDF »
- The Transmembrane Domain of the Amyloid Precursor Protein in Microsomal Membranes Is on Both Sides Shorter than Predicted.
- B. Grziwa, M. O. W. Grimm, C. L. Masters, K. Beyreuther, T. Hartmann, and S. F. Lichtenthaler (2003)
J. Biol. Chem.
278, 6803-6808
| Abstract »
| Full Text »
| PDF »
- Secretion and Intracellular Generation of Truncated Abeta in beta -Site Amyloid-beta Precursor Protein-cleaving Enzyme Expressing Human Neurons.
- E. B. Lee, D. M. Skovronsky, F. Abtahian, R. W. Doms, and V. M.-Y. Lee (2003)
J. Biol. Chem.
278, 4458-4466
| Abstract »
| Full Text »
| PDF »
- Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis.
- J. M. Redwine, B. Kosofsky, R. E. Jacobs, D. Games, J. F. Reilly, J. H. Morrison, W. G. Young, and F. E. Bloom (2003)
PNAS
100, 1381-1386
| Abstract »
| Full Text »
| PDF »
- Alzheimer's Disease, Neuropeptides, Neuropeptidase, and Amyloid-{beta} Peptide Metabolism.
- T. Saito, Y. Takaki, N. Iwata, J. Trojanowski, and T. C. Saido (2003)
Sci. Aging Knowl. Environ.
2003, pe1-1
| Abstract »
| Full Text »
- Amyloid beta -protein (Abeta ) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.
- G. Bitan, M. D. Kirkitadze, A. Lomakin, S. S. Vollers, G. B. Benedek, and D. B. Teplow (2003)
PNAS
100, 330-335
| Abstract »
| Full Text »
| PDF »
- Metalloenzyme-like Activity of Alzheimer's Disease beta -Amyloid. Cu-DEPENDENT CATALYTIC CONVERSION OF DOPAMINE, CHOLESTEROL, AND BIOLOGICAL REDUCING AGENTS TO NEUROTOXIC H2O2.
- C. Opazo, X. Huang, R. A. Cherny, R. D. Moir, A. E. Roher, A. R. White, R. Cappai, C. L. Masters, R. E. Tanzi, N. C. Inestrosa, et al. (2002)
J. Biol. Chem.
277, 40302-40308
| Abstract »
| Full Text »
| PDF »
- Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease.
- Y.-H. Suh and F. Checler (2002)
Pharmacol. Rev.
54, 469-525
| Abstract »
| Full Text »
| PDF »
- {beta}-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease.
- H. Fukumoto, B. S. Cheung, B. T. Hyman, and M. C. Irizarry (2002)
Arch Neurol
59, 1381-1389
| Abstract »
| Full Text »
| PDF »
- Dense-Core Senile Plaques in the Flemish Variant of Alzheimer's Disease Are Vasocentric.
- S. Kumar-Singh, P. Cras, R. Wang, J. M. Kros, J. van Swieten, U. Lubke, C. Ceuterick, S. Serneels, K.'l Vennekens, J.-P. Timmermans, et al. (2002)
Am. J. Pathol.
161, 507-520
| Abstract »
| Full Text »
| PDF »
- Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein.
- K. Niwa, K. Kazama, L. Younkin, S. G. Younkin, G. A. Carlson, and C. Iadecola (2002)
Am J Physiol Heart Circ Physiol
283, H315-H323
| Abstract »
| Full Text »
| PDF »
- beta -Secretase Processing in the Trans-Golgi Network Preferentially Generates Truncated Amyloid Species That Accumulate in Alzheimer's Disease Brain.
- J. T. Huse, K. Liu, D. S. Pijak, D. Carlin, V. M.-Y. Lee, and R. W. Doms (2002)
J. Biol. Chem.
277, 16278-16284
| Abstract »
| Full Text »
| PDF »
- Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.
- M. C. Sugarman, T. R. Yamasaki, S. Oddo, J. C. Echegoyen, M. P. Murphy, T. E. Golde, M. Jannatipour, M. A. Leissring, and F. M. LaFerla (2002)
PNAS
99, 6334-6339
| Abstract »
| Full Text »
| PDF »
- Molecular Cloning and Characterization of CALP/KChIP4, a Novel EF-hand Protein Interacting with Presenilin 2 and Voltage-gated Potassium Channel Subunit Kv4.
- Y. Morohashi, N. Hatano, S. Ohya, R. Takikawa, T. Watabiki, N. Takasugi, Y. Imaizumi, T. Tomita, and T. Iwatsubo (2002)
J. Biol. Chem.
277, 14965-14975
| Abstract »
| Full Text »
| PDF »
- A physiologic signaling role for the gamma -secretase-derived intracellular fragment of APP.
- M. A. Leissring, M. P. Murphy, T. R. Mead, Y. Akbari, M. C. Sugarman, M. Jannatipour, B. Anliker, U. Muller, P. Saftig, B. De Strooper, et al. (2002)
PNAS
| Abstract »
| Full Text »
| PDF »
- The Relationship between Abeta and Memory in the Tg2576 Mouse Model of Alzheimer's Disease.
- M. A. Westerman, D. Cooper-Blacketer, A. Mariash, L. Kotilinek, T. Kawarabayashi, L. H. Younkin, G. A. Carlson, S. G. Younkin, and K. H. Ashe (2002)
J. Neurosci.
22, 1858-1867
| Abstract »
| Full Text »
| PDF »
- Stable {beta}-Secretase Activity and Presynaptic Cholinergic Markers During Progressive Central Nervous System Amyloidogenesis in Tg2576 Mice.
- J.-T. Gau, M. L. Steinhilb, T.-C. Kao, C. J. D'Amato, J. R. Gaut, K. A. Frey, and R. S. Turner (2002)
Am. J. Pathol.
160, 731-738
| Abstract »
| Full Text »
| PDF »
- Repetitive Mild Brain Trauma Accelerates Abeta Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis.
- K. Uryu, H. Laurer, T. McIntosh, D. Pratico, D. Martinez, S. Leight, V. M.-Y. Lee, and J. Q. Trojanowski (2002)
J. Neurosci.
22, 446-454
| Abstract »
| Full Text »
| PDF »
- Correlation Between A{beta}x-40-, A{beta}x-42-, and A{beta}x-43-Containing Amyloid Plaques and Cognitive Decline.
- S. Parvathy, P. Davies, V. Haroutunian, D. P. Purohit, K. L. Davis, R. C. Mohs, H. Park, T. M. Moran, J. Y. Chan, and J. D. Buxbaum (2001)
Arch Neurol
58, 2025-2031
| Abstract »
| Full Text »
| PDF »
- Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice.
- C. Lesuisse, G. Xu, J. Anderson, M. Wong, J. Jankowsky, G. Holtz, V. Gonzalez, P. C. Y. Wong, D. L. Price, F. Tang, et al. (2001)
Hum. Mol. Genet.
10, 2525-2537
| Abstract »
| Full Text »
| PDF »
- A Portrait of Alzheimer Secretases--New Features and Familiar Faces.
- W. P. Esler and M. S. Wolfe (2001)
Science
293, 1449-1454
| Abstract »
| Full Text »
| PDF »
- Pathogenic APP mutations near the {gamma}-secretase cleavage site differentially affect A{beta} secretion and APP C-terminal fragment stability.
- C. De Jonghe, C. Esselens, S. Kumar-Singh, K. Craessaerts, S. Serneels, F. Checler, W. Annaert, C. Van Broeckhoven, and B. De Strooper (2001)
Hum. Mol. Genet.
10, 1665-1671
| Abstract »
| Full Text »
| PDF »
- BACE knockout mice are healthy despite lacking the primary {beta}-secretase activity in brain: implications for Alzheimer's disease therapeutics.
- S. L. Roberds, J. Anderson, G. Basi, M. J. Bienkowski, D. G. Branstetter, K. S. Chen, S. Freedman, N. L. Frigon, D. Games, K. Hu, et al. (2001)
Hum. Mol. Genet.
10, 1317-1324
| Abstract »
| Full Text »
| PDF »
- Insulin-Like Growth Factor I (IGF-I) Protects Cells from Apoptosis by Alzheimer's V642I Mutant Amyloid Precursor Protein through IGF-I Receptor in an IGF-Binding Protein-Sensitive Manner.
- T. Niikura, Y. Hashimoto, T. Okamoto, Y. Abe, T. Yasukawa, M. Kawasumi, T. Hiraki, Y. Kita, K. Terashita, K. Kouyama, et al. (2001)
J. Neurosci.
21, 1902-1910
| Abstract »
| Full Text »
| PDF »
- Characterization of Recombinant, Soluble {beta}-Secretase from an Insect Cell Expression System.
- W. D. Mallender, D. Yager, L. Onstead, M. R. Nichols, C. Eckman, K. Sambamurti, L. M. Kopcho, J. Marcinkeviciene, R. A. Copeland, and T. L. Rosenberry (2001)
Mol. Pharmacol.
59, 619-626
| Abstract »
| Full Text »
- Age-Dependent Changes in Brain, CSF, and Plasma Amyloid {beta} Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease.
- T. Kawarabayashi, L. H. Younkin, T. C. Saido, M. Shoji, K. H. Ashe, and S. G. Younkin (2001)
J. Neurosci.
21, 372-381
| Abstract »
| Full Text »
| PDF »
- Linkage of Plasma A{beta}42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease Pedigrees.
- N. Ertekin-Taner, N. Graff-Radford, L. H. Younkin, C. Eckman, M. Baker, J. Adamson, J. Ronald, J. Blangero, M. Hutton, and S. G. Younkin (2000)
Science
290, 2303-2304
| Abstract »
| Full Text »
- Presenilin-1 P264L Knock-In Mutation: Differential Effects on Abeta Production, Amyloid Deposition, and Neuronal Vulnerability.
- R. Siman, A. G. Reaume, M. J. Savage, S. Trusko, Y.-G. Lin, R. W. Scott, and D. G. Flood (2000)
J. Neurosci.
20, 8717-8726
| Abstract »
| Full Text »
| PDF »
- Effect of Apolipoprotein E Allele {{epsilon}}4 on the Initial Phase of Amyloid {beta}-Protein Accumulation in the Human Brain.
- M. Morishima-Kawashima, N. Oshima, H. Ogata, H. Yamaguchi, M. Yoshimura, S. Sugihara, and Y. Ihara (2000)
Am. J. Pathol.
157, 2093-2099
| Abstract »
| Full Text »
| PDF »
- Nonfibrillar diffuse amyloid deposition due to a {gamma}42-secretase site mutation points to an essential role for N-truncated A{beta}42 in Alzheimer's disease.
- S. Kumar-Singh, C. De Jonghe, M. Cruts, R. Kleinert, R. Wang, M. Mercken, B. De Strooper, H. Vanderstichele, A. Lofgren, I. Vanderhoeven, et al. (2000)
Hum. Mol. Genet.
9, 2589-2598
| Abstract »
| Full Text »
| PDF »
- Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation.
- K. Niwa, L. Younkin, C. Ebeling, S. K. Turner, D. Westaway, S. Younkin, K. H. Ashe, G. A. Carlson, and C. Iadecola (2000)
PNAS
97, 9735-9740
| Abstract »
| Full Text »
| PDF »
- Age-Related Amyloid {beta} Deposition in Transgenic Mice Overexpressing Both Alzheimer Mutant Presenilin 1 and Amyloid {beta} Precursor Protein Swedish Mutant Is Not Associated with Global Neuronal Loss.
- A. Takeuchi, M. C. Irizarry, K. Duff, T. C. Saido, K. Hsiao Ashe, M. Hasegawa, D. M. A. Mann, B. T. Hyman, and T. Iwatsubo (2000)
Am. J. Pathol.
157, 331-339
| Abstract »
| Full Text »
| PDF »
- In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease.
- D. M. Skovronsky, B. Zhang, M.-P. Kung, H. F. Kung, J. Q. Trojanowski, and V. M.-Y. Lee (2000)
PNAS
97, 7609-7614
| Abstract »
| Full Text »
| PDF »
- Mechanisms of Neurodegenerative Disorders: Part 1: Protein Aggregates.
- B. Wolozin and C. Behl (2000)
Arch Neurol
57, 793-796
| Full Text »
| PDF »
- Early-Onset Alzheimer Disease Caused by a New Mutation (V717L) in the Amyloid Precursor Protein Gene.
- J. R. Murrell, A. M. Hake, K. A. Quaid, M. R. Farlow, and B. Ghetti (2000)
Arch Neurol
57, 885-887
| Abstract »
| Full Text »
| PDF »
- Alzheimer's Disease, {beta}-Amyloid Protein and Zinc.
- X. Huang, M. P. Cuajungco, C. S. Atwood, R. D. Moir, R. E. Tanzi, and A. I. Bush (2000)
J. Nutr.
130, 1488S-1492
| Abstract »
| Full Text »
- Mutational Analysis of Intrinsic Regions of Presenilin 2 That Determine Its Endoproteolytic Cleavage and Pathological Function.
- K. Shirotani, K. Takahashi, W. Araki, K. Maruyama, and T. Tabira (2000)
J. Biol. Chem.
275, 3681-3686
| Abstract »
| Full Text »
| PDF »
- Protein Kinase C-dependent alpha -Secretase Competes with beta -Secretase for Cleavage of Amyloid-beta Precursor Protein in the Trans-Golgi Network.
- D. M. Skovronsky, D. B. Moore, M. E. Milla, R. W. Doms, and V. M.-Y. Lee (2000)
J. Biol. Chem.
275, 2568-2575
| Abstract »
| Full Text »
| PDF »
- AMY plaques in familial AD: Comparison with sporadic Alzheimer's disease.
- C. F. Lippa, M. L. Schmidt, L. E. Nee, T. Bird, D. Nochlin, C. Hulette, H. Mori, V. M.- Y. Lee, and J. Q. Trojanowski (2000)
Neurology
54, 100
| Abstract »
| Full Text »
| PDF »
- Regulation of Amyloid Precursor Protein Processing by Presenilin 1 (PS1) and PS2 in PS1 Knockout Cells.
- J. J. Palacino, B. E. Berechid, P. Alexander, C. Eckman, S. Younkin, J. S. Nye, and B. Wolozin (2000)
J. Biol. Chem.
275, 215-222
| Abstract »
| Full Text »
| PDF »
- Proteolytic processing and cell biological functions of the amyloid precursor protein.
- B De Strooper and W Annaert (2000)
J. Cell Sci.
113, 1857-1870
| Abstract »
| PDF »
|
|